NeuroPace (NPCE) Other Operating Expenses (2024 - 2026)

NeuroPace's Other Operating Expenses history runs 3 years deep, the most recent figure standing at $11.6 million for Q1 2026.

• In Q1 2026, Other Operating Expenses rose 5.27% year-over-year to $11.6 million; the TTM figure through Mar 2026 stood at $47.2 million (up 16.05% YoY), while the FY2025 annual figure was $46.6 million, up 17.42% from the prior year.
• Other Operating Expenses was $11.6 million for Q1 2026 at NeuroPace, up from $10.9 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $12.6 million in Q3 2025 to a low of $9.8 million in Q2 2024.
• Historically, Other Operating Expenses has averaged $11.0 million across 3 years, with a median of $11.0 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Other Operating Expenses gained 26.88% in 2025, then grew 5.27% in 2026.
• A 3-year view of Other Operating Expenses shows it stood at $10.0 million in 2024, then grew by 9.9% to $10.9 million in 2025, then advanced by 5.92% to $11.6 million in 2026.
• The last three Other Operating Expenses figures came in at $11.6 million (Q1 2026), $10.9 million (Q4 2025), and $12.6 million (Q3 2025), per Business Quant data.